No Image Provided

Inflow

VC Funding

Seed Angel-backed

Healthcare & Biotech Published 17 January 2022

Summary

In a significant market movement during January 2022, Inflow was the subject of a vc funding. The transaction achieved a gross valuation of £1,685,678. Leading the round was Yusuf Sherwani, Hoxton Ventures, Joshua Browder, Sarim Siddiqui, Route 66 Ventures, Maroof Ahmed.

This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.

Lead Investor / Acquirer

Yusuf Sherwani

Lead Investor / Acquirer

Hoxton Ventures

Lead Investor / Acquirer

Joshua Browder

Lead Investor / Acquirer

Sarim Siddiqui

Lead Investor / Acquirer

Route 66 Ventures

Lead Investor / Acquirer

Maroof Ahmed

Advising Broker

Undisclosed Firm

Related Deals in Healthcare & Biotech

Seed prioritised

VC Funding

Ternary Therapeutics

£3,600,000

Mar 2026

VC Funding

NuVision Biotherapies

£4,800,000

Mar 2026

VC Funding

Scan.com

£67,220,000

Sept 2026

VC Funding

Evaro

£18,000,000

Jan 2026

View Company Details

Financials, officers, full deal history

Original Source

This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.

View on Tech.eu Funding Explorer

Funding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.